Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
All articles — 31904 total
Element Solutions Inc heads into its October 27 earnings date with a sharp 9% weekly rally behind it, a clean short book, and a Street that remains broadly bullish but has quietly pulled price targets lower — creating…
TG Therapeutics enters the final stretch of Q3 with an unusual split: the stock is holding near multi-year highs while short sellers are quietly rebuilding positions at a pace that puts short interest among the…
MARA Holdings enters the final week of September with an unusual configuration: short sellers are pulling back even as the stock slides, and the borrow market is quietly tightening — a tension that makes the current…
Harrow, Inc. heads into the final week of September with a peculiar split: options traders are the most bullish they've been all year, while short sellers are quietly adding to an already-heavy position — and borrow…
XBI, the SPDR S&P Biotech ETF, enters the final days of September with a striking disconnect: options traders are at their most bearish in twelve months, yet the lending market has quietly loosened over the past…
DAL heads into its October 9 earnings report with short sellers cutting positions sharply, options traders turning distinctly bullish, and Warren Buffett quietly building a larger stake — a rare alignment of signals…
EnerSys enters the final week of September with a sharp contradiction at its core — short interest has jumped to its highest level in months while options traders have turned strikingly bullish. Short sellers have been…
Cytokinetics enters the final week of September in a difficult position. The stock has shed 6% over the past week and 16.5% over the past month, closing at $64.66 — well below the levels where the Street sees fair…
SBA Communications heads into the final week of September with a sharp selloff, rising short interest, and options traders at their most defensive posture in a year. The price action tells the dominant story. SBAC…
MRK enters the final week of September with a notable disconnect: the Street has spent the past month racing targets higher, yet the stock has slipped 5% over that same period — leaving a widening gap between analyst…
Charles River Laboratories attracted the most analyst action today. Barclays raised its target to $330 from $300 and kept a Buy rating. Mizuho followed, lifting its target to $295 from $264. Both moves came after CRL's…
Extreme Networks heads into its October 28 earnings date with short sellers backing away — even as the stock drifts lower and options traders edge more cautious. The headline short-interest move is the sharpest in…
DXP Enterprises heads into the final week of September with a stock up nearly 4% on the week and shorts steadily unwinding — a quiet but consistent message from the data. The short side has been retreating for weeks.…
BSX heads into its October 21 earnings call with a striking divergence: the CEO spent $9 million buying stock in early August, yet the analyst community has spent September methodically trimming targets. The insider…
An NVIDIA board director filed a flurry of sell transactions in early September, offloading shares worth over $400 million in total. Mark A. Stevens, an Independent Director, reported sales of roughly 1.75 million…
Short sellers are on the move. Data as of September 24 shows some sharp shifts in the past seven days — and a few names are flashing real squeeze risk. MRNA is the standout cover story. Short interest dropped nearly 2…
Allstate enters the final week of September in an awkward position: the stock has shed nearly 9% over seven sessions to $227.60, yet the options market is flashing one of its most bullish signals of the past year. The…
Akamai Technologies enters the final week of September with a sharp divergence at its core: short sellers have been covering steadily for a month while the Street, in a burst of activity on September 25, raised price…
DIGIS enters the final week of September with an unusual lending market story — availability has collapsed from historically loose levels to a still-very-comfortable position in just ten days, while the short score…
INDOMIM heads into the final week of September with a striking contradiction at its heart: the stock has surged 43% in a month, yet the people who know it best are selling. The insider activity is the clearest signal…
